285 related articles for article (PubMed ID: 20008222)
21. Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults.
Martin TG; Gajewski JL
Hematol Oncol Clin North Am; 2001 Feb; 15(1):97-120. PubMed ID: 11253611
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic hemopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission-similar outcomes after matched related and unrelated donor transplant: a study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon).
Muñoz A; Diaz-Heredia C; Diaz MA; Badell I; Verdeguer A; Martinez A; Gomez P; Perez-Hurtado JM; Bureo E; Fernandez-Delgado R; Gonzalez-Valentin ME; Maldonado MS
Pediatr Hematol Oncol; 2008 Jun; 25(4):245-59. PubMed ID: 18484470
[TBL] [Abstract][Full Text] [Related]
23. Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation.
Stirewalt DL; Guthrie KA; Beppu L; Bryant EM; Doney K; Gooley T; Appelbaum FR; Radich JP
Biol Blood Marrow Transplant; 2003 Mar; 9(3):206-12. PubMed ID: 12652472
[TBL] [Abstract][Full Text] [Related]
24. Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China.
Gao L; Zhang C; Gao L; Liu Y; Su Y; Wang S; Li B; Yang T; Yuan Z; Zhang X
J Hematol Oncol; 2015 Jul; 8():90. PubMed ID: 26208715
[TBL] [Abstract][Full Text] [Related]
25. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
[TBL] [Abstract][Full Text] [Related]
26. A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor.
Kako S; Morita S; Sakamaki H; Ogawa H; Fukuda T; Takahashi S; Kanamori H; Onizuka M; Iwato K; Suzuki R; Atsuta Y; Kyo T; Sakura T; Jinnai I; Takeuchi J; Miyazaki Y; Miyawaki S; Ohnishi K; Naoe T; Kanda Y
Leukemia; 2011 Feb; 25(2):259-65. PubMed ID: 21072046
[TBL] [Abstract][Full Text] [Related]
27. [Treatment of adult Ph-negative acute lymphoblastic leukemia].
Imai K
Rinsho Ketsueki; 2014 Oct; 55(10):1962-71. PubMed ID: 25297761
[No Abstract] [Full Text] [Related]
28. Which patients should I transplant with acute lymphoblastic leukemia?
Inbar T; Rowe JM; Horowitz NA
Best Pract Res Clin Haematol; 2017 Sep; 30(3):249-260. PubMed ID: 29050698
[TBL] [Abstract][Full Text] [Related]
29. Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Aldoss I; Stiller T; Cao TM; Palmer JM; Thomas SH; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1326-9. PubMed ID: 25842050
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study.
Martino R; Giralt S; Caballero MD; Mackinnon S; Corradini P; Fernández-Avilés F; San Miguel J; Sierra J
Haematologica; 2003 May; 88(5):555-60. PubMed ID: 12745275
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias.
Niederwieser D; Gentilini C; Hegenbart U; Lange T; Becker C; Wang SY; Bartsch K; Pönisch W; Raida M; Al-Ali H
Crit Rev Oncol Hematol; 2005 Nov; 56(2):275-81. PubMed ID: 16213741
[TBL] [Abstract][Full Text] [Related]
32. Three cases of renal relapse after allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia.
Huck K; Laws HJ; Meisel R; Traeger A; Bernbeck B; Schonberger S; Stackelberg VA; Pape H; Dilloo D
Haematologica; 2006 May; 91(5 Suppl):ECR07. PubMed ID: 16709515
[TBL] [Abstract][Full Text] [Related]
33. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission].
Takeuchi J
Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763
[No Abstract] [Full Text] [Related]
34. Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55-65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Ribera JM; García O; Gil C; Mercadal S; García-Cadenas I; Montesinos P; Barba P; Vives S; González-Campos J; Tormo M; Esteve J; López A; Moreno MJ; Ribera J; Alonso N; Bermúdez A; Amigo ML; Genescà E; García D; Vall-Llovera F; Bergua JM; Guàrdia R; Monteserín MC; Bernal T; Calbacho M; Martínez MP; Feliu E;
Leuk Res; 2018 May; 68():79-84. PubMed ID: 29574396
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study.
Balduzzi A; Valsecchi MG; Uderzo C; De Lorenzo P; Klingebiel T; Peters C; Stary J; Felice MS; Magyarosy E; Conter V; Reiter A; Messina C; Gadner H; Schrappe M
Lancet; 2005 Aug 20-26; 366(9486):635-42. PubMed ID: 16112299
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Young Adults with Acute Lymphoblastic Leukemia.
Kansagra A; Litzow M
Curr Hematol Malig Rep; 2017 Jun; 12(3):187-196. PubMed ID: 28353017
[TBL] [Abstract][Full Text] [Related]
37. [Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].
Wang J; Huang X; Jiang B; Qin Y; Bao L; Jiang H; Chen H; Jia J; Yang S; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):120-5. PubMed ID: 24606652
[TBL] [Abstract][Full Text] [Related]
38. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
[TBL] [Abstract][Full Text] [Related]
39. Dose-intensive therapy for adult acute lymphoblastic leukemia.
Finiewicz KJ; Larson RA
Semin Oncol; 1999 Feb; 26(1):6-20. PubMed ID: 10073558
[TBL] [Abstract][Full Text] [Related]
40. Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents.
Ishida H; Adachi S; Hasegawa D; Okamoto Y; Goto H; Inagaki J; Inoue M; Koh K; Yabe H; Kawa K; Kato K; Atsuta Y; Kudo K
Pediatr Blood Cancer; 2015 May; 62(5):883-9. PubMed ID: 25545836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
